The Impact of Preoperative Combined Pectoserratus and/or Interpectoral Plane (Pectoralis Type II) Blocks on Opioid Consumption, Pain, and Overall Benefit of Analgesia in Patients Undergoing Minimally Invasive Cardiac Surgery: A Prospective, Randomized, Controlled, and Triple-blinded Trial

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Authors' conclusion

Preoperative PSPB + IPPB reduced 24-hour postextubation opioid consumption, pain at extubation, and OBAS.

Study context

Population
Patients undergoing elective right-lateral minimally invasive cardiac surgery (MICS)
Participants
60 patients
Comparison
Preoperative PSPB + IPPB with ropivacaine 0.5% vs saline
Primary endpoint
Total intravenous morphine milligram equivalents administered
Follow-up
First 24 hours after extubation
Methodological detailsprospective, triple-blinded, single-centre, Operating room and ICU of a university hospital
  • Prospective
  • Triple-blinded
  • Single-centre
  • Operating room and ICU of a university hospital

Primary result

As reported in the abstract

Total intravenous morphine milligram equivalents
  • PSPB + IPPB vs Saline: P = 0.025

Secondary outcomes

OutcomeP value
Overall Benefit of Analgesia Score (OBAS) · 24 hours after extubationSignificantly lowerP = 0.043
VAS pain · after extubationSignificantly lowerP = 0.030

Visual Analogue Scale (VAS) pain · later points

VAS did not differ between groups at later points

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

The Impact of Preoperative Combined Pectoserratus and/or Interpectoral Plane (Pectoralis Type II) Blocks on Opioid Consumption, Pain, and Overall Benefit of Analgesia in Patients Undergoing Minimally Invasive Cardiac Surgery: A Prospective, Randomized, Controlled, and Triple-blinded Trial. J Cardiothorac Vasc Anesth. Published 28 June 2024. doi:10.1053/j.jvca.2024.06.036

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.